2017

Oral Human Papillomavirus Infection: Differences in Prevalence Between Sexes and Concordance With Genital Human Papillomavirus Infection, NHANES 2011 to 2014. Sonawane K, Suk R, Chiao EY, Chhatwal J, Qiu P, Wilkin T, Nyitray AG, Sikora AG, Deshmukh AA.

Tenascin-C and Integrin α9 Mediate Interactions of Prostate Cancer with the Bone Microenvironment. San Martin R, Pathak R, Jain A, Jung SY, Hilsenbeck SG, Piña-Barba MC, Sikora AG, Pienta KJ, Rowley DR.

Racial/ethnic variation in the prevalence of vaccine-related human papillomavirus genotypes. Montealegre JR, Varier I, Bracamontes CG, Dillon LM, Guillaud M, Sikora AG, Follen M, Adler-Storthz K, Scheurer ME.

Risk factors for oropharynx cancer in a cohort of HIV-infected veterans. Chew EY, Hartman CM, Richardson PA, Zevallos JP, Sikora AG, Kramer JR, Chiao EY.

2016

Racial disparities in incidence of human papillomavirus-associated oropharyngeal cancer in an urban population. Ramer I, Varier I, Zhang D, Demicco EG, Posner MR, Misiukiewicz K, Genden EM, Miles BA, Teng MS, Sikora AG.

Therapeutic HPV Cancer Vaccine Targeted to CD40 Elicits Effective CD8+ T-cell Immunity. Yin W, Duluc D, Joo H, Xue Y, Gu C, Wang Z, Wang L, Ouedraogo R, Oxford L, Clark A, Parikh F, Kim-Schulze S, Thompson-Snipes L, Lee SY, Beauregard C, Woo JH, Zurawski S, Sikora AG, Zurawski G, Oh S.

Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes. Varier I, Keeley BR, Krupar R, Patsias A, Dong J, Gupta N, Parasher AK, Genden EM, Miles BA, Teng M, Bakst RL, Gupta V, Misiukiewicz KJ, Chiao EY, Scheurer ME, Laban S, Zhang D, Ye F, Cui M, Demicco EG, Posner MR, Sikora AG.

5-Fluorouracil targets thymidylate synthase in the selective suppression of TH17 cell differentiation. Wang J, Peng L, Zhang R, Zheng Z, Chen C, Cheung KL, Cui M, Bian G, Xu F, Chiang D, Hu Y, Chen Y, Lu G, Yang J, Zhang H, Yang J, Zhu H, Chen SH, Liu K, Zhou MM, Sikora AG, Li L, Jiang B, Xiong H.

Expression and clinical significance of MAGE and NY-ESO-1 cancer-testis antigens in adenoid cystic carcinoma of the head and neck. Veit JA, Heine D, Thierauf J, Lennerz J, Shetty S, Schuler PJ, Whiteside T, Beutner D, Meyer M, Grünewald I, Ritter G, Gnjatic S, Sikora AG, Hoffmann TK, Laban S.

Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes. Varier I, Keeley BR, Krupar R, Patsias A, Dong J, Gupta N, Parasher AK, Genden EM, Miles BA, Teng M, Bakst RL, Gupta V, Misiukiewicz KJ, Chiao EY, Scheurer ME, Laban S, Zhang D, Ye F, Cui M, Demicco EG, Posner MR, Sikora AG.

2015

The In Ovo Chick Chorioallantoic Membrane (CAM) Assay as an Efficient Xenograft Model of Hepatocellular Carcinoma. Li M, Pathak RR, Lopez-Rivera E, Friedman SL, Aguirre-Ghiso JA, Sikora AG.

Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma. Rettig EM, Wentz A, Posner MR, Gross ND, Haddad RI, Gillison ML, Fakhry C, Quon H, Sikora AG, Stott WJ, Lorch JH, Gourin CG, Guo Y, Xiao W, Miles BA, Richmon JD, Andersen PE, Misiukiewicz KJ, Chung CH, Gerber JE, Rajan SD, D'Souza G.

Myeloid cell-derived inducible nitric oxide synthase suppresses M1 macrophage polarization. Lu G, Zhang R, Geng S, Peng L, Jayaraman P, Chen C, Xu F, Yang J, Li Q, Zheng H, Shen K, Wang J, Liu X, Wang W, Zheng Z, Qi CF, Si C, He JC, Liu K, Lira SA, Sikora AG, Li L, Xiong H.

Phenotype and function of nasal dendritic cells. Lee H, Ruane D, Law K, Ho Y, Garg A, Rahman A, Esterházy D, Cheong C, Goljo E, Sikora AG, Mucida D, Chen BK, Govindraj S, Breton G, Mehandru S.

Requirement for innate immunity and CD90⁺ NK1.1⁻ lymphocytes to treat established melanoma with chemo-immunotherapy. Moskalenko M, Pan M, Fu Y, de Moll EH, Hashimoto D, Mortha A, Leboeuf M, Jayaraman P, Bernardo S, Sikora AG, Wolchok J, Bhardwaj N, Merad M, Saenger Y.

2014

Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancer. Parikh F, Duluc D, Imai N, Clark A, Misiukiewicz K, Bonomi M, Gupta V, Patsias A, Parides M, Demicco EG, Zhang DY, Kim-Schulze S, Kao J, Gnjatic S, Oh S, Posner MR, Sikora AG.

iNOS expression in CD4+ T cells limits Treg induction by repressing TGFβ1: combined iNOS inhibition and Treg depletion unmask endogenous antitumor immunity. Jayaraman P, Alfarano MG, Svider PF, Parikh F, Lu G, Kidwai S, Xiong H, Sikora AG.

TGFβ receptor 1: an immune susceptibility gene in HPV-associated cancer. Levovitz C, Chen D, Ivansson E, Gyllensten U, Finnigan JP, Alshawish S, Zhang W, Schadt EE, Posner MR, Genden EM, Boffetta P, Sikora AG.

Prediagnostic serum levels of inflammatory biomarkers are correlated with future development of lung and esophageal cancer. Keeley BR, Islami F, Pourshams A, Poustchi H, Pak JS, Brennan P, Khademi H, Genden EM, Abnet CC, Dawsey SM, Boffetta P, Malekzadeh R, Sikora AG.

Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of TSC2. Lopez-Rivera E, Jayaraman P, Parikh F, Davies MA, Ekmekcioglu S, Izadmehr S, Milton DR, Chipuk JE, Grimm EA, Estrada Y, Aguirre-Ghiso J, Sikora AG.

Reduced impact of nodal metastases as a prognostic factor for tonsil cancer in the HPV era, published in European Archives of Oto-Rhino-Laryngology. By P.M. Vila, C.L. Stucken, L. Morris, M. Posner, E. Genden, P. Boffetta, A. Sikora

Inducible nitric oxide synthase (iNOS) drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of TSC2, published in Cancer Research. By E. Lopez-Rivera, P. Jayaraman, F. Parikh, M. A. Davies, S. Ekmekcioglu, S. Izadmehr, D.R. Milton, J.E. Chipuk, E. Grimm, Y. Estrada, J. Aguirre-Ghiso, A. Sikora

Protein markers profiling in different T classification in laryngeal squamous cell carcinoma, published in Head and Neck. By W. Chen, F. Ye, M. Cui, A.G. Sikora, X. Wang, P. Wang, X. Cui, X. Guo, W. Zhu, D.Y. Zhang

Survival Outcomes in Advanced Laryngeal Cancer, published in Archives of Otolaryngology – Head and Neck Surgery. By U. Megawalu, A.G. Sikora

Prediagnostic Serum Levels of Inflammatory Biomarkers Predict Aerodigestive Cancer Risk, published in Cancer Science. By B.R. Keeley, F. Islami, J. Pak, E.M. Genden, P. Boffetta, R. Malekzadeh, A.G. Sikora

TGFBR1: an immune susceptibility gene for HPV-related head and neck cancer, published in Cancer Research. By C. Levovitz, D. Chen, E. Ivansson, U. Gyllensten, J. Finnigan, S. Alshawish, W. Zhang, E. Schadt, M. Posner, J. McKay, P. Brennan, P. Boffetta, A.G. Sikora

iNOS expression in CD4+ T cells limits Treg induction by repressing TGF-b: combined iNOS inhibition and Treg depletion unmask endogenous anti-tumor immunity. By P. Jayaraman, F. Parikh, M. Alfarano, P. Svider, S. Kidwai, H. Xiong, A. G. Sikora

Cisplatin-based concurrent chemoradiotherapy antagonizes pre-existing anti-tumor immunity in patients with HPV-positive head and neck cancer, published in Cancer Research. By F. Parikh, A. Clark, A. Patsias, P. Jayaraman, A. Yerasi, S. Kim-Schulze, K. Misiukiewicz, M. Bonomi, E. Genden, D. Deluc, S. Oh, M. Posner, A.G. Sikora

2013

Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer, published in Cancer. By K. Jain, A. Sikora, S. Baxi, L. Morris

T Cell-Derived Inducible Nitric Oxide Synthase Switches Off Th17 Cell Differentiation, published in Journal of Experimental Medicine. By J. Yang, R. Zhang, G. Lu, Y. Shen, C. Zhu, M. Cui, W. Wang, P. Arnaboldi, L. Peng, M. Tang, M. Gupta, C. Qi, P. Jayaraman, H. Zhu, B. Jiang, S. Chen, J. He, A. Ting, V. Kuchroo, H. Morse, K. Ozato, A. Sikora, H. Xiong

2012

Anatomic Sites At Elevated Risk Of Second Primary Cancer After An Index Head And Neck Cancer, published in Cancer Causes and Control. By L. Morris, A. Sikora, R. Hayes, S. Patel, I. Ganly

Prognostic Significance Of P16 In Locoregionally Advanced Head And Neck Cancer Treated With Concurrent 5FU, Hydroxyurea, Cetuximab, And Intensity-Modulated Radiation Therapy, published in Oncology Reports. By C.C. Tong, K.H.V. Lau, M. Rivera, D. Cannan, J. Aguirre-Ghiso, A. Sikora, V. Gupta, K. Forsythe, E.C. Ko, K. Misiukiewicz, V. Gurudutt, M. Teng, S. Packer, E. Genden and J. Kao

Tumor-Expressed Inducible Nitric Oxide Synthase Controls Induction Of Functional Myeloid-Derived Suppressor Cells Through Modulation Of Vascular Endothelial Growth Factor Release, published by Journal of Immunology. By P. Jayaraman, F. Parikh, E. Lopez-Rivera, D. Cannan, Y. Hailemichael, W. Overwijk, S.H. Chen, A. Sikora

Discrimination Of Benign And Neoplastic Mucosa With A High-Resolution Microendoscope (HRME) In Head And Neck Cancer, published in Annals of Surgical Oncology. By P. Vila, C. Park, L. Levy, G. Goldstein, M. Teng, M. Rivera, E. Genden, R. Richards-Kortum, V. Gurudutt, A. Sikora

Sensitization To The Mitochondrial Pathway Of Apoptosis Augments Melanoma Tumor Cell Responses To Chemotherapeutic Regimens, published in Cell Death and Disease. By R. Anvekar, J. Asciolla, E. Rivera, K. Floros, R. Elkholi, G. Morven-Belbin, A. Sikora*, J. Chipuk

2011

Second Primary Cancers After An Index Head And Neck Cancer: Subsite-Specific Trends In The Era Of HPV-Associated Oropharyngeal Cancer, published in Journal of Clinical Oncology. By L. Morris, A. Sikora, S. Patel, R. Hayes, I. Ganley

Transoral Robotic Resection And Reconstruction For Head And Neck Cancer, published in Laryngoscope. By E. Genden, T. Kotz, C. Tong, C. Smith, A. Sikora, M. Teng, S. Packer, W. Lawson, J. Kao